Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041736 | SCV000065432 | benign | not specified | 2008-02-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000041736 | SCV000169769 | benign | not specified | 2011-07-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000041736 | SCV000231899 | benign | not specified | 2014-07-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041736 | SCV000317193 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001514232 | SCV001722029 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001276155 | SCV001748490 | benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003887891 | SCV004707248 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV001514232 | SCV005287604 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001276155 | SCV001462009 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |